Sandostatin LAR 20mg Injection
Marketer
Novartis India Ltd
Salt Composition
Octreotide acetate (20mg)
Overview Sandostatin LAR 20mg Injection
Octreotide acetate 20mg injection (brand name Sandostatin LAR) treats acromegaly, carcinoid tumors, and gastrointestinal bleeding from esophageal varices. It also helps prevent post-pancreatic surgery complications. Administration is exclusively by a qualified medical professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician. Consistent use is crucial for optimal therapeutic effect. Discontinuation should only occur under medical supervision. Common side effects may include diarrhea, abdominal discomfort, nausea, constipation, gas, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and a complete list of all medications you currently use.
Primary Ingredients of Sandostatin LAR 20mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Sandostatin LAR 20mg Injection
Overgrowth disorders | Neuroendocrine neoplasms | Gastroesophageal haemorrhage
Major Benefits of Sandostatin LAR 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Sandostatin LAR 20mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Sandostatin LAR 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Sandostatin LAR 20mg Injection works:
Octreotide depot 20mg injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication suppresses the activity of various hormones, including growth hormone, and reduces esophageal bleeding via vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sandostatin LAR 20mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Octreotide depot 20mg injection is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Octreotide depot 20mg injection is likely compatible with breastfeeding. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by a 20mg Sandostatin LAR injection.
KidneySAFE IF PRESCRIBED
Octreotide acetate 20mg extended-release injection poses no known safety concerns for patients with renal impairment; dosage modification is not advised.
LiverCAUTION
Octreotide long-acting release injection (20mg) requires careful administration in individuals with hepatic impairment. Dosage modification for this injection may be necessary. Physician consultation is recommended.
What if you forget to take Sandostatin LAR 20mg Injection :
Should you forget a Sandostatin LAR 20mg Injection, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Sandostatin LAR 20mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Somatostatin Receptor Ligands |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Somatostatin receptor ligands |
3,018 People bought this recently